By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


iPierian Inc. 

951 Gateway Boulevard
2nd Floor
South San Francisco  California  94080  U.S.A.
Phone: 650-872-4700 Fax: n/a



Start Up

Company News
Bristol-Myers Squibb Company (BMY) Acquires iPierian Inc. In $725 Million Deal 4/29/2014 6:43:59 AM
iPierian Inc. Announces Oral Presentation Of Tau Antibody Preclinical Efficacy Study Which Showed Significant Reduction In Alzheimer’s Disease Progression 11/12/2013 11:28:20 PM
iPierian Inc. to Present Data on Tau Antibody Preclinical Efficacy Study for Alzheimer’s Program at Society For Neuroscience Annual Meeting 11/1/2013 6:53:24 AM
iPierian Inc. Nabs $30 Million Series A Financing for Launch of Spin-Out, True North Therapeutics 9/4/2013 6:41:28 AM
iPierian Inc. Appoints Pamela B. Conley as Vice President of Research 5/21/2012 10:33:01 AM
iPierian Inc. Turns Its Stem Cell Technology on Alzheimer's, Antibody Drugs 5/21/2012 8:18:48 AM
iPierian Inc. Appoints Nancy Stagliano as CEO; Peter Van Vlasselaer, Interim CEO, Becomes Executive Chairman of the Board 9/7/2011 7:33:18 AM
iPierian Inc. Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup 6/15/2011 6:18:23 AM
iPierian Inc., Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives 5/13/2011 7:33:37 AM
iPierian Inc. to Present at Future Leaders in the Biotech Industry Conference 4/12/2011 9:04:36 AM